[go: up one dir, main page]

WO1998049292A3 - Polypeptides associes a des recepteurs activateurs et leurs applications biologiques - Google Patents

Polypeptides associes a des recepteurs activateurs et leurs applications biologiques Download PDF

Info

Publication number
WO1998049292A3
WO1998049292A3 PCT/FR1998/000883 FR9800883W WO9849292A3 WO 1998049292 A3 WO1998049292 A3 WO 1998049292A3 FR 9800883 W FR9800883 W FR 9800883W WO 9849292 A3 WO9849292 A3 WO 9849292A3
Authority
WO
WIPO (PCT)
Prior art keywords
karap
kar
receptors
receptor
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR1998/000883
Other languages
English (en)
Other versions
WO1998049292A2 (fr
Inventor
Eric Vivier
Alessandro Moretta
Lucia Olcese
Frederic Vely
Elena Tomasello
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9705411A external-priority patent/FR2762844B1/fr
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to EP98921586A priority Critical patent/EP0977855A2/fr
Priority to JP54668798A priority patent/JP2002503094A/ja
Priority to CA002287916A priority patent/CA2287916A1/fr
Publication of WO1998049292A2 publication Critical patent/WO1998049292A2/fr
Publication of WO1998049292A3 publication Critical patent/WO1998049292A3/fr
Anticipated expiration legal-status Critical
Priority to US10/902,886 priority patent/US7569666B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente demande concerne de nouveaux moyens permettant de diagnostiquer, prévenir, pallier, traiter un fonctionnement anormal ou non désiré de récepteurs KAR (Killer cell Activatory Receptor), contreparties non inhibitrices de récepteurs KIR (Killer cell Inhibitory Receptors) de type immunoglobuline ou de type lectine. Elle est notamment relative à de nouveaux polypeptides KARAP (KAR-Associated Proteins) et à leurs applications biologiques. Un polypeptide KARAP, selon l'invention, est naturellement associé à un récepteur KAR, et en l'absence d'un tel KARAP, ledit récepteur KAR est naturellement incapable de transduire un signal activateur détectable. La présente demande vise également des méthodes d'obtention ou d'identification de tels polypeptides KARAP.
PCT/FR1998/000883 1997-04-30 1998-04-30 Polypeptides associes a des recepteurs activateurs et leurs applications biologiques Ceased WO1998049292A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP98921586A EP0977855A2 (fr) 1997-04-30 1998-04-30 Polypeptides associes a des recepteurs activateurs et leurs applications biologiques
JP54668798A JP2002503094A (ja) 1997-04-30 1998-04-30 活性化レセプタに会合される新しいポリペプチド及びその生物学的応用
CA002287916A CA2287916A1 (fr) 1997-04-30 1998-04-30 Polypeptides associes a des recepteurs activateurs et leurs applications biologiques
US10/902,886 US7569666B2 (en) 1997-04-30 2004-08-02 Polypeptides associated with activatory receptors and their biological applications

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR97/05411 1997-04-30
FR9705411A FR2762844B1 (fr) 1997-04-30 1997-04-30 Nouveaux polypeptides associes a des recepteurs activateurs et leurs applications biologiques
FR9800927 1998-01-28
FR98/00927 1998-01-28

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09403980 A-371-Of-International 1998-04-30
US64553903A Division 1997-04-30 2003-08-22

Publications (2)

Publication Number Publication Date
WO1998049292A2 WO1998049292A2 (fr) 1998-11-05
WO1998049292A3 true WO1998049292A3 (fr) 1999-05-27

Family

ID=26233499

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1998/000883 Ceased WO1998049292A2 (fr) 1997-04-30 1998-04-30 Polypeptides associes a des recepteurs activateurs et leurs applications biologiques

Country Status (5)

Country Link
US (1) US7569666B2 (fr)
EP (1) EP0977855A2 (fr)
JP (2) JP2002503094A (fr)
CA (1) CA2287916A1 (fr)
WO (1) WO1998049292A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1003861E (pt) * 1997-08-01 2007-01-31 Schering Corp Proteínas de membrana de células de mamíferos;reagentes relacionados
US6416973B1 (en) 1997-08-01 2002-07-09 Schering Corporation Nucleic acids encoding mammalian cell membrane protein MDL-1
AU2002220591A1 (en) * 2000-09-20 2002-04-02 Institut National De La Sante Et De La Recherche Medicale (I.N.S.E.R.M) Means for the identification of compounds capable of inhibiting karap-transduced signals
EP1370651A4 (fr) * 2001-02-23 2005-04-06 Human Genome Sciences Inc 70 proteines humaines secretees
JP2008502597A (ja) * 2004-04-30 2008-01-31 イネイト・ファーマ Ｎｋ型ｌｄｇｌのような免疫増殖性障害を処置するための組成物および方法
CN104829720B (zh) 2005-01-06 2019-01-01 诺和诺德公司 Kir结合剂和使用其的方法
JP6424757B2 (ja) * 2015-07-14 2018-11-21 株式会社島津製作所 ポリペプチドの質量分析方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020604A1 (fr) * 1994-01-28 1995-08-03 Schering Corporation Anticorps specifiques des antigenes de cellules tueuses naturelles des mammiferes et utilisations correspondantes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020604A1 (fr) * 1994-01-28 1995-08-03 Schering Corporation Anticorps specifiques des antigenes de cellules tueuses naturelles des mammiferes et utilisations correspondantes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
L. OLCESE ET AL.: "Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells.", THE JOURNAL OF IMMUNOLOGY, vol. 158, no. 11, 1 June 1997 (1997-06-01), BALTIMORE, MD, ÉTATS-UNIS, pages 5083 - 5086, XP002052878 *
M. BLÉRY ET AL.: "Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs.", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 14, 4 April 1997 (1997-04-04), BALTIMORE, MD, ÉTATS-UNIS, pages 8989 - 8996, XP002052877 *

Also Published As

Publication number Publication date
JP2009005699A (ja) 2009-01-15
EP0977855A2 (fr) 2000-02-09
JP2002503094A (ja) 2002-01-29
CA2287916A1 (fr) 1998-11-05
WO1998049292A2 (fr) 1998-11-05
US20050130130A1 (en) 2005-06-16
US7569666B2 (en) 2009-08-04

Similar Documents

Publication Publication Date Title
EP0921395A3 (fr) Méthode pour déterminer des fragments de la protein dans les milieux biologiques
WO1996020954A3 (fr) Domaines fonctionnellement actifs de proteines transducteurs de signaux et activateurs de transcription (stat)
WO2000020449A3 (fr) PROTEINES MODIFIEES DE LA SUPERFAMILLE DU TGF-$g(B)
DK0692025T3 (da) Gærceller, der er konstrueret således, at de producerer surrogater for proteiner i feromonsystemet, og anvendelser deraf
AU5579099A (en) Electrochemical affinity assay
WO1999024463A3 (fr) Proteines contenant une sequence signal
WO2001012662A3 (fr) Proteines associees a la membrane
WO2000000610A3 (fr) Proteines contenant un peptide signal humain
AU7181298A (en) Simultaneous humand abo and Rh(D) blood typing or antibody screening by flow ytometry
NZ323795A (en) Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
WO1995010628A3 (fr) Transduction de signaux par l'intermediaire de cd28
WO2000015793A3 (fr) Proteines gpcr humaines
AU582688B2 (en) Analysis element for the determination of coagulation parameters
WO2000029583A3 (fr) Proteines de la superfamille des immunoglobulines
WO2000012711A3 (fr) Proteines membranaires de canal humaines
WO1998049292A3 (fr) Polypeptides associes a des recepteurs activateurs et leurs applications biologiques
WO2000018922A8 (fr) Proteines humaines associees a des glucides
WO2000009709A3 (fr) Proteases et proteines associees
WO1999058692A3 (fr) Proteines associees a l'apoptose humaine
WO2000012703A3 (fr) Molecules associees au transport de proteines
CA2203246A1 (fr) Alk-7 (kinase analogue a l'activine), un recepteur de la serine threonine kinase
WO2000017355A3 (fr) Proteines humaines associees au cytosquelette
AU3186397A (en) Prion protein binding proteins and uses thereof
WO1999033981A3 (fr) Proteines contenant des sequences-signaux humaines
WO1999058558A3 (fr) Proteines de signalisation cellulaire

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

ENP Entry into the national phase

Ref document number: 2287916

Country of ref document: CA

Ref country code: CA

Ref document number: 2287916

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 546687

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1998921586

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09403980

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1998921586

Country of ref document: EP